在Wegovy和Ozempic等减重药物帮助下,美国肥胖率略有下降。 U.S. obesity rates drop slightly, aided by weight-loss medications like Wegovy and Ozempic.

美国肥胖率十年来首次略有下降,Wegovy和Ozempic等减重药物发挥着关键作用。 Obesity rates in the U.S. have dropped slightly for the first time in over a decade, with weight-loss medications like Wegovy and Ozempic playing a key role. 日本医学协会卫生论坛的一项研究表明,成人特别是妇女和老年人肥胖症减少。 A study in JAMA Health Forum shows a decrease in obesity among adults, especially women and older adults. 卫生数据公司Triveta发现,这些药物导致更多的病人被诊断患有睡眠性肾上腺炎和2型糖尿病等疾病,有可能在最初增加医疗使用,但有可能通过早期治疗节省费用。 Health data firm Truveta found that these drugs lead to more patients being diagnosed with conditions like sleep apnea and type 2 diabetes, potentially increasing healthcare use initially but possibly saving costs through early treatment.